Stem Cell Therapy and ARDS: Promising Potential Treatment
- Details
- Published: Wednesday, 08 April 2020 09:16
Stem Cell Therapy and ARDS
Acute respiratory distress syndrome, or ARDS, was a relatively rare condition until the advent of the novel coronavirus and COVID-19. Prior to the global pandemic of 2020, ARDS affected fewer than 200,000 individuals per year, but that number has risen significantly.
What Is ARDS?
ARDS is an acronym for acute respiratory distress syndrome. It’s also known as acute lung injury and noncardiac pulmonary edema. The National Heart, Lung, and Blood Institute defines it as,
“a serious lung condition that causes low blood oxygen. People who develop ARDS are usually ill due to another disease or a major injury. In ARDS, fluid builds up inside the tiny air sacs of the lungs, and the surfactant breaks down. Surfactant is a foamy substance that keeps the lungs fully expanded so that a person can breathe.”
Read more: Stem Cell Therapy and ARDS: Promising Potential...
Each year, tens of thousands of individuals in the US alone are diagnosed with a spinal cord injury. According to the 
Hand in hand with the nation's obesity epidemic comes a diabetes epidemic. According to the 
Few medical treatments today have garnered as much scrutiny as stem cell therapy. This treatment offers hope and the chance for health to patients suffering from a wide range of medical conditions, from myriad types of cancer to anemia, and everything in between. However, it has also be quite controversial, with the federal government weighing in on its use and legality.
Today, stem cell treatment is incredibly important, and much better understood than it once was. The controversy surrounding the treatment has also faded due to new techniques. What should you know about stem cells and their incredible potential?
Stem cell treatment has been a hot topic, and hotly debated treatment method, for over 20 years now. While the controversy surrounding stem cells has largely died away due to the fact that embryonic stem cells are no longer used, there remains a great deal of uncertainty regarding many aspects of this treatment option.
Parkinson's disease (PD) is a degenerative brain condition that leads to a dramatic loss in a person's quality of life. According to the 
Alzheimer's disease is truly devastating. According to the Alzheimer's Association, the disease affects over 5 million individuals currently, and cost the nation $259 billion in 2017. Those costs are predicted to reach $1.1 trillion by the year 2050. Every 66 seconds someone develops the disease. Ultimately, one in three American seniors will die with Alzheimer's or a related condition.
Of course, Alzheimer's affects more than just those who develop it. In 2017, over 15 million Americans cared for an Alzheimer's patient without being paid for it. 35% of those who cared for a patient with Alzheimer's or a related disease reported that their own health suffered as a result.
Muscular dystrophy (MD) is not a single disease, but a collection of related conditions. These range from Duchenne/Becker muscular dystrophy to distal dystrophy, congenital muscular dystrophy, Emery-Dreifuss muscular dystrophy, and more. Each condition is unique, yet they all share common symptoms and outcomes.
Multiple sclerosis (MS) is a debilitating disease that affects over 2.3 million people worldwide, with nearly 400,000 of those sufferers living in the United States, according to